Drugs / c-Met/PD-L1 CAR-T cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03672305 | Oct 2018 → Oct 2019 | hepatocellular carcinoma | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | c-Met/PD-L1 CAR-T cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03672305 ↗ |
| Route | Intravenous | “Infusion way:Steady intravenous drip within 15 to 30 minutes” NCT03672305 ↗ |